简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-06-09 10:27 HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors
2025-06-06 14:44 iFIT Adds More Ways to Workout, Brings Club Pilates and YogaSix Content to Its Platform
2025-06-06 14:06 RAD 2025: Long-Term Data on Nemluvio® (nemolizumab) Demonstrate its Favorable Safety Profile and Sustained and Increased Improvements in Itch and Skin Lesions in Patients With Atopic Dermatitis up to Two Years
2025-06-06 11:32 QPS Celebrates 30th Anniversary
2025-06-06 11:25 Fujirebio Announces Strategic Collaboration with Stanford Medicine to Advance Infectious Disease Research
2025-06-06 11:22 Biocytogen Secures Japan Patent for RenMab Platform, Expands Global Patent Portfolio for RenMice Fully Human Antibody/TCR Platform
2025-06-05 16:15 Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US
2025-06-05 14:04 Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009)
2025-06-05 10:37 Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only
2025-06-04 13:11 ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis
2025-06-04 13:05 BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 2025
2025-06-04 10:47 Byondis Announces First Patient Dosed in Phase 1 Clinical Trial of Novel SIRPα-Directed Monoclonal Antibody BYON4228 in Patients With Advanced or Metastatic Solid Tumors
2025-06-04 10:41 European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD
2025-06-03 14:07 iFIT Expands Global Reach with Rollout of AI Coach in 19 Countries
2025-06-03 14:04 BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA’s Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 2025
2025-06-03 10:01 Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy, Improved Hematocrit Control in Polycythemia Vera
2025-05-30 10:52 US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA™ (adalimumab-bwwd) Injection
2025-05-29 12:21 BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology
2025-05-29 11:21 Cargill Earns #1 Global Ranking for Removing Trans Fats From Edible Oils Portfolio
2025-05-29 11:15 Pimicotinib Demonstrates Best-in-Class Potential with Significant Efficacy and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumor

Business Wire Weibo

Press Releases

Latest Releases